Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

15-06-2022 | Metastasis | Letter to the Editor

Letter to the editor regarding “Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival”

Authors: Maria José Veloza Vega, Manuela Gallo, Gonzalo Ucros, Patricia Bernal

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 11/2022

Excerpt

Dear Editor, …

Jannin A, Lamartina L, Moutarde C, Djennaoui M, Lion G, Chevalier B, Vantyghem MC, Deschamps F, Hadoux J, Baudin E, Schlumberger M, Leboulleux S, Do Cao C. Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival. Eur J Nucl Med Mol Imaging. 2022;49(7):2401–13. https://doi.org/10.1007/s00259-022-05697-w.

World Health Organization International Agency for Research on Cancer (IARC). GLOBOCAN 2020: Colombia fact sheets. [homepage on the internet]; 2020 [cited 2022 March 28]. Available from: https://gco.iarc.fr/today/data/factsheets/populations/170-colombia-fact-sheets.pdf.

Chung J-K, Cheon GJ. Radioiodine therapy in differentiated thyroid cancer: the first targeted therapy in oncology. Endocrinol Metab. 2014;29:233. https://doi.org/10.3803/enm.2014.29.3.233.CrossRef

Title: Letter to the editor regarding “Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival”
Authors: Maria José Veloza Vega
Manuela Gallo
Gonzalo Ucros
Patricia Bernal
Publication date: 15-06-2022
Publisher: Springer Berlin Heidelberg
Keywords: Metastasis
Radioiodine Therapy
Bone Metastasis
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 11/2022
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-022-05869-8

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Letter to the editor regarding “Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival”

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 11/2022

Classification of 18F-Flutemetamol scans in cognitively normal older adults using machine learning trained with neuropathology as ground truth

[18F]PSMA-1007 PET/CT in the detection of neoplastic lumbosacral plexopathy as an emerging and underestimated spread of prostate cancer

Development and validation of a radiomic model for the diagnosis of dopaminergic denervation on [18F]FDOPA PET/CT

In patients with well-differentiated neuroendocrine tumours, there is no apparent benefit of somatostatin analogues after disease control by peptide receptor radionuclide therapy

Diverse PSMA expression in primary prostate cancer: reason for negative [68Ga]Ga-PSMA PET/CT scans? Immunohistochemical validation in 40 surgical specimens

[68 Ga]Ga-FAPI-46 PET for non-invasive detection of pulmonary fibrosis disease activity